Follow the NeuroThera Labs Inc. stock price and the full management transaction log of the company, a publicly traded company based in Canada. Shares are quoted on the CA market, under the supervision of SEDI. Market capitalisation: €32.3m. The latest transaction was filed on 18 August 2026 (11 - Acquisition or disposition carried out privately). Among the most active insiders: SciSparc Ltd.. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
NeuroThera Labs Inc. is a company focused on developing innovative therapies for neurological disorders. It is listed on the Toronto Stock Exchange.